P-090: IS A DEDICATED MARKETING APPROVAL OF HYDROXYUREA IN SICKLE CELL DISEASE MAY INCREASE THE CLINICAL BENEFIT OF THE DRUG?

Bibliographic Details
Main Authors:	GALACTÉROS F., VOSKARIDOU E., HABIBI A., CANNAS G., JOSEPH L., LOKO G., DE MONTALEMBERT M.
Format:	Article
Language:	English
Published:	Wiley 2022-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000873248.60171.71

Internet